Itron, Inc. (ITRI) Tops Q4 EPS by 20c; Guides FY12 EPS, Revs
Tweet
Share
E-mailGet Alerts ITRI Hot Sheet
Price: $102.72 +0.11%
Financial Fact:
Product development: 39.39M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Product development: 39.39M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Itron, Inc. (NASDAQ: ITRI) reported Q4 EPS of $1.19, $0.20 better than the analyst estimate of $0.99. Revenue for the quarter came in at $642.5 million versus the consensus estimate of $582.14 million.
Itron, Inc. sees FY2012 EPS of $3.80-$4.20, versus the consensus of $3.87. Itron, Inc. sees FY2012 revenue of $2.1-$2.3 billion, versus the consensus of $2.26 billion.
For earnings history and earnings-related data on Itron, Inc. (ITRI) click here.
Itron, Inc. sees FY2012 EPS of $3.80-$4.20, versus the consensus of $3.87. Itron, Inc. sees FY2012 revenue of $2.1-$2.3 billion, versus the consensus of $2.26 billion.
For earnings history and earnings-related data on Itron, Inc. (ITRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
